Saturday, October 1, 2022
HomeHEALTHPfizer raises hopes amid anti-vaccination protests

Pfizer raises hopes amid anti-vaccination protests

The new variant of the Corona is lost in the power of the Omicron. In France alone, more than half a million people have been identified in Corona in the last 24 hours. In this situation, raising the light of hope, Pfizer has started testing the vaccine of Omicron. Germany, on the other hand, is up in arms over anti-vaccination and anti-sanctions protests. The opposite is true in Israel. The country is preparing for the fourth dose of corona vaccine.

Protests in Germany against vaccinations and sanctions Thousands of people took to the streets to protest. During this time they chanted various anti-vaccine slogans. In this situation, Pfizer, a vaccine manufacturer in the United States, sent a message of relief to the world who lost their way in Omicron. They have started testing the vaccine of this variant.

Omicron can also infect humans by bypassing some of the vaccines that are usually given in two-dose doses to stop the corona epidemic. For those who have not yet been vaccinated or who have been vaccinated with Dudoz, the pharmaceutical company said it plans to invent an antimicrobial vaccine.

In addition, a test is currently being conducted to give Omicron-based fourth doses to those who took three doses of Pfizer-Bioentech three to six months ago.

So far 1,400 people have registered to take part in the test. Now their body’s tolerance and safety will be studied, said Pfizer-Bioentech.
In a statement, Katherine Johnson, Pfizer’s head of vaccine research and development, said: “Current research and real-world data (RWD) show that booster doses provide the greatest protection against the risk of disease or hospitalization after being infected with Omicron.” But over time, that is likely to change. In the future, booster doses may be helpful to get protection from Omicron or any other type.

Pfizer says the two-dose vaccine may not be enough to protect against omicron. Immunizations can gradually reduce the risk of hospitalization or death.

According to the US Centers for Disease Control and Prevention, a third dose of MRNA vaccine, such as Pfizer-Bioentech, provides 90 percent protection for a patient from being hospitalized after contracting Covid-19.

Additional booster doses have also been introduced in some countries. But a recent Israeli study found that the fourth dose of the mRNA vaccine, while potentiating andbody, was not sufficient to protect against infections such as omikron.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments